SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020565
Filing Date
2018-08-08
Accepted
2018-08-08 17:08:29
Documents
45
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20180630.htm 10-Q 1601541
2 EX-31.1 tcon-ex311_10.htm EX-31.1 9271
3 EX-32.1 tcon-ex321_12.htm EX-32.1 5376
  Complete submission text file 0001564590-18-020565.txt   5509302

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tcon-20180630.xml EX-101.INS 1225436
5 XBRL TAXONOMY EXTENSION SCHEMA tcon-20180630.xsd EX-101.SCH 45246
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20180630_cal.xml EX-101.CAL 34963
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20180630_def.xml EX-101.DEF 136772
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20180630_lab.xml EX-101.LAB 306053
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20180630_pre.xml EX-101.PRE 222694
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 181002314
SIC: 2836 Biological Products, (No Diagnostic Substances)